Amphastar P (AMPH)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 351,121 | 248,860 | 199,739 | 143,340 | 131,923 |
| Revenue | US$ in thousands | 644,395 | 498,987 | 437,768 | 349,846 | 322,357 |
| Gross profit margin | 54.49% | 49.87% | 45.63% | 40.97% | 40.92% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $351,121K ÷ $644,395K
= 54.49%
The gross profit margin of Amphastar Pharmaceuticals Inc has shown a consistent upward trend over the past five years, increasing from 40.92% in 2019 to 54.49% in 2023. This indicates that the company has been able to effectively control its cost of goods sold relative to its revenue, leading to improved profitability at the gross profit level. The steady growth in gross profit margin suggests that Amphastar Pharmaceuticals Inc has been successful in managing its production costs and pricing strategies, ultimately resulting in stronger financial performance. Overall, the increasing gross profit margin reflects positively on the company's operational efficiency and profitability in recent years.
Peer comparison
Dec 31, 2023